Melanie Marshall
Technik-/Wissenschafts-/F&E-Leiter bei OSSDSIGN AB
Aktive Positionen von Melanie Marshall
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OSSDSIGN AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 | - |
Karriereverlauf von Melanie Marshall
Ehemalige bekannte Positionen von Melanie Marshall
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Technik-/Wissenschafts-/F&E-Leiter | 20.11.2009 | - |
Ausbildung von Melanie Marshall
Wheaton College (Massachusetts) | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 2 |
Schweden | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OSSDSIGN AB | Health Technology |
Private Unternehmen | 1 |
---|---|
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Health Technology |
- Börse
- Insiders
- Melanie Marshall
- Erfahrung